Prostate cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Horwich
A
A
Institute of Cancer Research and Royal Marsden Hospital, Sutton, UK.
Parker
C
C
Bangma
C
C
Kataja
V
V
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D017024:Chemotherapy, Adjuvant; D003131:Combined Modality Therapy; D051517:Digital Rectal Examination; D055088:Early Detection of Cancer / Q000401:mortality; D005060:Europe / Q000453:epidemiology; D005500:Follow-Up Studies; D006801:Humans; D015994:Incidence; D008297:Male; D009362:Neoplasm Metastasis / Q000628:therapy; D009367:Neoplasm Staging; D017430:Prostate-Specific Antigen / Q000097:blood; D011468:Prostatectomy; D011471:Prostatic Neoplasms / Q000175:diagnosis* / Q000473:pathology / Q000628:therapy*; D011878:Radiotherapy; D016032:Randomized Controlled Trials as Topic; D018570:Risk Assessment; D055502:Secondary Prevention; D016019:Survival Analysis; D016896:Treatment Outcome
D017430:Prostate-Specific Antigen